Collaboration to introduce lyophilized ODT-based prescription medicines for Brazil and other key markets
Key Highlights:
· InstaPill enters into an agreement with Aché Laboratórios Farmacêuticos S.A. to co-develop Oral Dispersing Tablets
· Partnership leverages InstaPill’s proprietary lyophilized oral dispersing tablet (ODT) platform.
· Marks InstaPill’s first collaboration in Latin America, expanding access to advanced drug delivery solutions.
InstaPill Private Limited (InstaPill) today announced its strategic partnership with Aché Laboratórios Farmacêuticos S.A. (Aché) to co-develop the first of several prescription pharmaceutical products using InstaPill’s proprietary lyophilized oral dispersing tablet (ODT) platform for the Brazilian and other Latin American markets.
Commenting on the partnership, Ankit Gupta, CEO of InstaPill, stated: “We are extremely pleased with our maiden partnership with Aché, which pairs InstaPill’s core technical capabilities in oral lyophilizates with Aché’s leading go-to-market expertise. This represents a significant step forward in our mission to expand InstaPill’s unique technology throughout Latin America.”
About InstaPill Private Limited
InstaPill is a globally recognized CDMO specializing in orally disintegrating tablets using our proprietary InstaPill® technology platform. Our facility in Bengaluru, India, houses experienced pharma professionals who have successfully developed and manufactured products registered and distributed in over 50 countries, and has installed capacity of 300 million tablets. With a commitment to innovation and compliance, InstaPill’s facilities have GMP approvals from the US-FDA, EU, Health Canada, MHRA, and TGA regulatory authorities.
From early formulation through regulatory approvals and commercial supply, our integrated services are designed to reduce time to market, enhance product performance, and ensure consistent quality at scale.
For more details visit: https://insta-pill.com/about-us/
About Aché Laboratórios Farmacêuticos S.A.
Aché is a Brazilian pharmaceutical company founded nearly 60 years ago with a mission to improve people's lives. A leader in the prescription market in Brazil, Aché's portfolio also includes solutions in generic medicines and over-the-counter (OTC) products. This success is driven by a commitment to excellence and a focus on investments in in-house research and development (R&D), partnerships for open innovation, and in-licensed products.
Aché is recognized as a top-of-mind company and a brand of choice among Brazilian healthcare professionals, with over 350 brands and 900 drug presentations across more than 150 therapeutic categories and 30 medical specialties. Today, Aché's products reach 20 countries across Latin America, Africa, Asia, and Europe, in addition to its home base in Brazil. For details visit:
https://www.ache.com.br/en/about-us/
Commenting on the partnership, Ankit Gupta, CEO of InstaPill, stated: “We are extremely pleased with our maiden partnership with Aché, which pairs InstaPill’s core technical capabilities in oral lyophilizates with Aché’s leading go-to-market expertise. This represents a significant step forward in our mission to expand InstaPill’s unique technology throughout Latin America.”
About InstaPill Private Limited
InstaPill is a globally recognized CDMO specializing in orally disintegrating tablets using our proprietary InstaPill® technology platform. Our facility in Bengaluru, India, houses experienced pharma professionals who have successfully developed and manufactured products registered and distributed in over 50 countries, and has installed capacity of 300 million tablets. With a commitment to innovation and compliance, InstaPill’s facilities have GMP approvals from the US-FDA, EU, Health Canada, MHRA, and TGA regulatory authorities.
From early formulation through regulatory approvals and commercial supply, our integrated services are designed to reduce time to market, enhance product performance, and ensure consistent quality at scale.
For more details visit: https://insta-pill.com/about-us/
About Aché Laboratórios Farmacêuticos S.A.
Aché is a Brazilian pharmaceutical company founded nearly 60 years ago with a mission to improve people's lives. A leader in the prescription market in Brazil, Aché's portfolio also includes solutions in generic medicines and over-the-counter (OTC) products. This success is driven by a commitment to excellence and a focus on investments in in-house research and development (R&D), partnerships for open innovation, and in-licensed products.
Aché is recognized as a top-of-mind company and a brand of choice among Brazilian healthcare professionals, with over 350 brands and 900 drug presentations across more than 150 therapeutic categories and 30 medical specialties. Today, Aché's products reach 20 countries across Latin America, Africa, Asia, and Europe, in addition to its home base in Brazil. For details visit:
https://www.ache.com.br/en/about-us/
No comments:
Post a Comment
Thanks for posting your comments. Do continue to visit
http://blogspot.siliconvillage.net for more news, features and interviews in business, technology, gadgets related areas.